stockrowImmunome, Inc. (IMNM) vs Septerna, Inc. (SEPN)
- Immunome, Inc. IMNM 18.49 +3.24%
- Septerna, Inc. SEPN 48.84 +3.15%
Immunome, Inc. and Septerna, Inc. are both Biotechnology companies. Immunome, Inc. and Septerna, Inc. are of similar size ($2.2B and $2.1B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against 16.7%. Immunome, Inc. has the higher net margin (0.00% vs −24.5%) and the lower return on invested capital (−3,323.0% vs −189.0%). Across the 15 metrics below, Septerna, Inc. leads on 10 and Immunome, Inc. on 5.
Valuation
Profitability
| Metric | IMNM | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (44.04%) | 0.00% |
| Net margin | 0.00% | (24.51%) | 0.00% |
| Free cash flow margin | 0.00% | 118.93% | 0.00% |
| Return on equity | (64.03%) | (6.34%) | (50.12%) |
| Return on assets | (59.03%) | (4.94%) | (45.60%) |
| Return on invested capital | (3,322.99%) | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack